Nasson Boroumand

I successfully launched and scaled Heartwise, consisting of a cardiac rehab application, a mobile device suite, and a cloud-based analytics platform. We increased compliance from 40% to 84% and reduced the readmission rate to .5% vs. the 20% national average. We also reduced readmission by 30%, fatal myocardial infarction by 28%, and all-cause mortality after one year by 58%. Additionally, the clinical partner benefitted from a 154% reduction in the cost of program maintenance and supported a 43% reduction in clinician workload while doubling case manager patient capacity and increasing patient access to the program.

Cardiac rehabilitation programs grew from around 600 patients per year in Southern California to over 5,000 yearly.

My research generated onboarding flows that contributed to the high study conversion rate (around 60) and included high daily active participant and engagement rates based on analytics data. The preliminary data submitted to the FDA demonstrated strong correlations between stress, situation, and blood pressure and showcased high validity and accuracy between cuff baseline measurements and light sensor pulse transit time (PTT) measurements.

I conducted research that generated detailed personas of potential customers, along with implementing a comprehensive evaluation of legal issues, telco companies, and pain points for deployment. We influenced partnership strategies, partner development, testing locations, and marketing strategies. We also trained technicians and team members within the manufacturing team to facilitate the delivery of units ahead of schedule. I also successfully oversaw the pilot testing, debut, and promotion of Project Loon.